Jung Sun Kim

1.7k total citations
56 papers, 1.3k citations indexed

About

Jung Sun Kim is a scholar working on Oncology, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, Jung Sun Kim has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 12 papers in Pharmaceutical Science and 8 papers in Molecular Biology. Recurrent topics in Jung Sun Kim's work include Advancements in Transdermal Drug Delivery (11 papers), Lung Cancer Treatments and Mutations (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). Jung Sun Kim is often cited by papers focused on Advancements in Transdermal Drug Delivery (11 papers), Lung Cancer Treatments and Mutations (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). Jung Sun Kim collaborates with scholars based in South Korea, Ethiopia and United States. Jung Sun Kim's co-authors include Dae‐Duk Kim, Han-Gon Choi, Chang‐Koo Shim, Chul Soon Yong, Jong Soo Woo, Jong Oh Kim, Prabagar Balakrishnan, Dong Hoon Oh, Bong Kyu Yoo and Won Seok Lee and has published in prestigious journals such as Cancer, International Journal of Radiation Oncology*Biology*Physics and Molecules.

In The Last Decade

Jung Sun Kim

54 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jung Sun Kim South Korea 17 454 316 241 214 186 56 1.3k
Toshikiro Kimura Japan 22 566 1.2× 394 1.2× 217 0.9× 45 0.2× 84 0.5× 68 1.5k
Matilde Merino‐Sanjuán Spain 20 543 1.2× 268 0.8× 266 1.1× 53 0.2× 43 0.2× 81 1.4k
Chandraiah Godugu India 22 140 0.3× 426 1.3× 144 0.6× 54 0.3× 98 0.5× 87 1.5k
Venkatesh Pooladanda India 19 86 0.2× 380 1.2× 100 0.4× 171 0.8× 116 0.6× 32 1.6k
Joon Seok Bang South Korea 14 102 0.2× 320 1.0× 204 0.8× 43 0.2× 50 0.3× 63 1.2k
Mahmoud El‐Badry Egypt 24 950 2.1× 318 1.0× 80 0.3× 29 0.1× 65 0.3× 92 1.7k
Tomomi Hatanaka Japan 17 485 1.1× 172 0.5× 103 0.4× 20 0.1× 300 1.6× 62 1.0k
Reason Wilken United States 11 67 0.1× 720 2.3× 239 1.0× 59 0.3× 112 0.6× 26 1.7k
Mahdi Hatamipour Iran 18 115 0.3× 533 1.7× 132 0.5× 64 0.3× 32 0.2× 37 1.6k
Ryoko Yumoto Japan 25 303 0.7× 654 2.1× 887 3.7× 53 0.2× 37 0.2× 96 2.3k

Countries citing papers authored by Jung Sun Kim

Since Specialization
Citations

This map shows the geographic impact of Jung Sun Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung Sun Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung Sun Kim more than expected).

Fields of papers citing papers by Jung Sun Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung Sun Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung Sun Kim. The network helps show where Jung Sun Kim may publish in the future.

Co-authorship network of co-authors of Jung Sun Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Jung Sun Kim. A scholar is included among the top collaborators of Jung Sun Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung Sun Kim. Jung Sun Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Jung Sun, et al.. (2024). Transporter Genes and statin-induced Hepatotoxicity. Cardiovascular Drugs and Therapy. 39(4). 801–810. 3 indexed citations
2.
Park, Siyeon, Seongyeol Park, Tae Min Kim, et al.. (2024). Resistance mechanisms of EGFR tyrosine kinase inhibitors, in EGFR exon 20 insertion-mutant lung cancer. European Journal of Cancer. 208. 114206–114206. 2 indexed citations
3.
Jang, Eun Jeong, Jung Sun Kim, Jeong Yee, et al.. (2023). Construction of a risk scoring system using clinical factors and RYR2 polymorphisms for bleeding complications in patients on direct oral anticoagulants. Frontiers in Pharmacology. 14. 1290785–1290785. 1 indexed citations
4.
Kim, Jung Sun, Sak Lee, Jeong Yee, et al.. (2023). Novel Gene Polymorphisms for Stable Warfarin Dose in a Korean Population: Genome-Wide Association Study. Biomedicines. 11(8). 2308–2308. 1 indexed citations
5.
Lee, Mi-Jin, Jimin Han, Jae‐Yeon Lee, et al.. (2023). Comparison of pharmacogenomic information for drug approvals provided by the national regulatory agencies in Korea, Europe, Japan, and the United States. Frontiers in Pharmacology. 14. 1205624–1205624. 4 indexed citations
6.
Kim, Jung Sun, So-Yeon Kim, Jaemoon Koh, et al.. (2022). Predictive role of galectin-3 for immune checkpoint blockades (ICBs) in advanced or metastatic non-small cell lung cancer: a potential new marker for ICB resistance. Journal of Cancer Research and Clinical Oncology. 149(6). 2355–2365. 7 indexed citations
8.
Kim, Jung Sun, Shin Hye Yoo, Yejin Kim, et al.. (2020). Implication of the Life-Sustaining Treatment Decisions Act on End-of-Life Care for Korean Terminal Patients. Cancer Research and Treatment. 52(3). 917–924. 35 indexed citations
9.
Seo, Mi‐Suk, et al.. (2018). Analysis of Sugars Content by Genotypes in 82 Radish (Raphanus sativus L.). Korean Journal of Plant Resources. 31(5). 453–465. 4 indexed citations
10.
Yan, Yi-Dong, Dong Won Lee, Jung Sun Kim, et al.. (2011). Evaluation of physicochemical properties, skin permeation and accumulation profiles of salicylic acid amide prodrugs as sunscreen agent. International Journal of Pharmaceutics. 419(1-2). 154–160. 17 indexed citations
11.
Balakrishnan, Prabagar, Dong Hoon Oh, Jung Sun Kim, et al.. (2011). Evaluation of salicylic acid fatty ester prodrugs for UV protection. Drug Development and Industrial Pharmacy. 37(7). 841–848. 8 indexed citations
12.
Yoon, In‐Soo, Min‐Koo Choi, Jung Sun Kim, et al.. (2010). Pharmacokinetics and first-pass elimination of metoprolol in rats: contribution of intestinal first-pass extraction to low bioavailability of metoprolol. Xenobiotica. 41(3). 243–251. 48 indexed citations
13.
Park, Sang Eun, Jung Sun Kim, Yeon-Weol Lee, Hwa‐Seung Yoo, & Chong-Kwan Cho. (2009). Antitumor Activity of Water Extracts From Cordyceps Militaris in NCI-H460 Cell Xenografted Nude Mice. Journal of Acupuncture and Meridian Studies. 2(4). 294–300. 36 indexed citations
14.
Kim, Jung Sun, et al.. (2006). Current Management of Acute Bronchiolitis in Incheon. 16(2). 150–161. 1 indexed citations
15.
Kim, Jin Cheon, Jin Cheon Kim, Tae Won Kim, et al.. (2005). Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer. International Journal of Radiation Oncology*Biology*Physics. 63(2). 346–353. 94 indexed citations
16.
Park, In Ja, Hee Cheol Kim, Chang Sik Yu, et al.. (2005). Lymph Node Metastases of Prostatic Adenocarcinoma in the Mesorectum in Patients with Rectal Cancer. Cancer Research and Treatment. 37(2). 129–129. 5 indexed citations
17.
Kim, Jung Sun, et al.. (2004). Recognition of Osteoporosis and Analysis of Influencing Factors.. Gajeong yihag hoeji. 16(7). 542–549. 1 indexed citations
18.
Bian, Shengjie, et al.. (2003). In vitro evaluation of patch formulations for topical delivery of gentisic acid in rats. European Journal of Pharmaceutical Sciences. 18(2). 141–147. 18 indexed citations
19.
Lim, Kyung‐Min, Jooyoung Lee, Jung Sun Kim, & Jin‐Ho Chung. (1999). Prostaglandin H Synthase and Lipoxygenase Mediated Activation of Xenobiotics in Platelets. Advances in experimental medicine and biology. 469. 631–637. 1 indexed citations
20.
Kim, Jung Sun. (1990). Sex role effects on female response to illness.. PubMed. 19(2). 135–55. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026